BSE Prices delayed by 5 minutes... << Prices as on May 08, 2026 - 3:59PM >>   ABB  7009.05 ATS - Market Arrow  [-2.51]  ACC  1397.6 ATS - Market Arrow  [-1.28]  AMBUJA CEM  444.25 ATS - Market Arrow  [-1.57]  ASIAN PAINTS  2600.25 ATS - Market Arrow  [2.80]  AXIS BANK  1269.4 ATS - Market Arrow  [-1.78]  BAJAJ AUTO  10710.85 ATS - Market Arrow  [0.98]  BANKOFBARODA  264.05 ATS - Market Arrow  [-2.33]  BHARTI AIRTE  1834 ATS - Market Arrow  [0.41]  BHEL  404.65 ATS - Market Arrow  [-0.41]  BPCL  302.85 ATS - Market Arrow  [-1.54]  BRITANIAINDS  5519.2 ATS - Market Arrow  [-5.02]  CIPLA  1347.7 ATS - Market Arrow  [-1.11]  COAL INDIA  456.35 ATS - Market Arrow  [-2.15]  COLGATEPALMO  2196.75 ATS - Market Arrow  [1.38]  DABUR INDIA  487.6 ATS - Market Arrow  [3.73]  DLF  608.4 ATS - Market Arrow  [-1.68]  DRREDDYSLAB  1293 ATS - Market Arrow  [-1.06]  GAIL  166.5 ATS - Market Arrow  [-0.57]  GRASIM INDS  2958.15 ATS - Market Arrow  [-0.06]  HCLTECHNOLOG  1198.6 ATS - Market Arrow  [1.28]  HDFC BANK  781.2 ATS - Market Arrow  [-1.84]  HEROMOTOCORP  5321.5 ATS - Market Arrow  [-0.38]  HIND.UNILEV  2287.9 ATS - Market Arrow  [0.66]  HINDALCO  1043 ATS - Market Arrow  [-1.19]  ICICI BANK  1264.8 ATS - Market Arrow  [-1.01]  INDIANHOTELS  673.3 ATS - Market Arrow  [0.62]  INDUSINDBANK  949.85 ATS - Market Arrow  [0.34]  INFOSYS  1179.2 ATS - Market Arrow  [1.44]  ITC LTD  307.4 ATS - Market Arrow  [-0.08]  JINDALSTLPOW  1246.2 ATS - Market Arrow  [-0.98]  KOTAK BANK  380.55 ATS - Market Arrow  [0.32]  L&T  3973.6 ATS - Market Arrow  [-1.22]  LUPIN  2377.9 ATS - Market Arrow  [-3.33]  MAH&MAH  3321.7 ATS - Market Arrow  [-1.45]  MARUTI SUZUK  13739.9 ATS - Market Arrow  [-0.20]  MTNL  32.11 ATS - Market Arrow  [-0.53]  NESTLE  1478.65 ATS - Market Arrow  [0.18]  NIIT  74.92 ATS - Market Arrow  [0.74]  NMDC  88.8 ATS - Market Arrow  [-1.55]  NTPC  402.2 ATS - Market Arrow  [0.44]  ONGC  279.25 ATS - Market Arrow  [-1.66]  PNB  107.2 ATS - Market Arrow  [-1.79]  POWER GRID  313.9 ATS - Market Arrow  [0.00]  RIL  1435.7 ATS - Market Arrow  [0.00]  SBI  1019.55 ATS - Market Arrow  [-6.62]  SESA GOA  296.45 ATS - Market Arrow  [-2.91]  SHIPPINGCORP  338.75 ATS - Market Arrow  [5.96]  SUNPHRMINDS  1847.3 ATS - Market Arrow  [0.70]  TATA CHEM  781.9 ATS - Market Arrow  [-2.83]  TATA GLOBAL  1175.95 ATS - Market Arrow  [2.04]  TATA MOTORS  355.35 ATS - Market Arrow  [-1.09]  TATA STEEL  214.45 ATS - Market Arrow  [-1.20]  TATAPOWERCOM  436 ATS - Market Arrow  [-0.73]  TCS  2394.85 ATS - Market Arrow  [-0.29]  TECH MAHINDR  1463.05 ATS - Market Arrow  [1.03]  ULTRATECHCEM  11956 ATS - Market Arrow  [-1.55]  UNITED SPIRI  1281.1 ATS - Market Arrow  [0.14]  WIPRO  197.95 ATS - Market Arrow  [0.30]  ZEETELEFILMS  95.08 ATS - Market Arrow  [0.57]  

GlobalSpace Technologies Ltd.

Directors Report

BSE: 540654ISIN: INE632W01016INDUSTRY: IT Consulting & Software

BSE   Rs 33.48   Open: 28.40   Today's Range 27.95
33.48
+5.58 (+ 16.67 %) Prev Close: 27.90 52 Week Range 13.67
28.50
You can view full text of the latest Director's Report for the company.
Market Cap. (Rs.) 115.07 Cr. P/BV 2.11 Book Value (Rs.) 15.89
52 Week High/Low (Rs.) 29/14 FV/ML 10/1 P/E(X) 0.00
Bookclosure 03/11/2023 EPS (Rs.) 0.00 Div Yield (%) 0.00
Year End :2025-03 

Your directors take pleasure in presenting the 15th Annual Report of the Company together with the Audited
Statement of Accounts for the year ended March 31, 2025.

1. FINANCIAL SUMMARY & OPERATIONAL HIGHLIGHTS:

a. Financial Results

The Company's performance during the year ended March 31, 2025, as compared to the previous
financial year, is summarized below:

Particulars

Standalone

Consolidated

2024-2025

2023-2024

2024-2025

2023-2024

Income

2,933.03

2,917.20

4309.17

Not Applicable

Less: Expenses

2878.83

2,912.77

4276.00

Profit / (Loss) before Tax

(221.46)

(381.23)

(242.48)

Less: Provision for Tax

(37.75)

(28.13)

(42.57)

Current Tax

-

-

2.59

Deferred Tax

(37.75)

(28.13)

(45.15)

Income Tax of earlier
years w/off

Nil

Nil

Nil

Exceptional Income

Nil

Nil

Nil

Exceptional Expenditure

Nil

Nil

Nil

Profit After Tax

(183.71)

(353.11)

(199.92)

Total Comprehensive
Income

(190.12)

(352.59)

(214.48)

APPROPRIATION:

Interim Dividend

Nil

Final Dividend

Nil

Tax on distribution of dividend

Nil

Transfer of General Reserve

Nil

Balance carried to Balance sheet

(190.12)

b. Company's Performance Review:

During the Financial Year ended March 31, 2025, the Company's total Revenue from operations is INR
2,932.48 Lakhs as against INR 2904.80 Lakhs in the corresponding previous Financial Year ended
March 31, 2024.

The Profit/(Loss) after tax for the Financial Year ended March 31, 2025, is INR (183.71 Lakhs) as
against Profit of INR (353.11 Lakhs) in the corresponding previous Financial Year ended March 31,
2024.

c. Operations and change in nature of business, if any:

The Company continues to be engaged in the activities pertaining to Information Technology and

Communication industry, including providing customized software solutions and other support services to
enterprises.

The Company's business activity is that of providing technology enabled business enhancement solutions.
There was no change in the nature of the business of the Company during the year under review.

d. Share Capital:

During the financial year under review, there has been no change in the Authorized, Issued, Subscribed,
and Paid-up Share Capital of the Company.

As of March 31, 2025, the Authorized Share Capital of the Company is INR 35,00,00,000/- divided into

3,50,00,000/- equity shares of INR 10/- each.

Further, the Issued, Subscribed, and Paid-up Share Capital of the Company as of March 31, 2025, is INR
34,36,98,030/- divided into 3,43,69,803/- equity shares of INR 10/- each.

e. Dividend:

Owing to loss during the year under review, your directors have thought it prudent not to recommend
any dividend for the financial year 2024-2025.

f. Unpaid Dividend and IEPF:

During the year under review, neither the Company was liable to, nor the Company has transferred
any amount or shares to the Investor Education & Protection Fund (IEPF) and an amount of INR.
28,722.80/ is lying in Unpaid dividend A/c of the Company.

g. Transfer to Reserves:

The Company has not transferred any amount to General Reserve Account during the financial year
under review.

h. Report on performance of Subsidiaries, Associates and loint Venture:

During the year under review, the Company has 2 Subsidiary Company. Further the Company did not have
any associate and joint venture Company

The Details of the Subsidiaries are given below:

SUBSIDIARY COMPANIES:

1. Innopharm Healthcare Private Limited (CIN: U74999MH2015PTC267088), is a Private Limited
Company incorporated on 03/08/2015. The authorized Share Capital of the Company is INR

10,00,000/- divided into 1,00,000 equity shares of INR 10/- each.

Issued, Subscribed, and Paid-up Share Capital of the Company INR 10,00,000/- divided into

1,00,000 equity shares of INR 10/- each.

The Company has a 51 % equity stake in Innopharm Healthcare Private Limited and has thus become
a subsidiary of the Company under Section 2(87) of the Companies Act, 2013.

2. Miljon Medi App Private Limited (CIN: U46497MH2025PTC444146), being converted from LLP
into Private Limited Company w.e.f March 29, 2025 in which the Company was holding an
investment. Consequent to such conversion, M/s Miljon Medi App Private Limited has become
subsidiary of the Company in accordance with applicable provisions of the Companies Act, 2013.

The authorized Share Capital of the Company is INR 100,000/- divided into 10,000 equity shares

of INR 10/- each.

Issued, Subscribed, and Paid-up Share Capital of the Company INR 100,000/- divided into 10,000
equity shares of INR 10/- each.

The Company has a 95 % equity stake in Miljon Medi App Private Limited and has thus become a
subsidiary of the Company under Section 2(87) of the Companies Act, 2013.

Further, a statement containing salient features of the financial statements of the Company's
subsidiaries as required in Form AOC 1 is appended as
Annexure I to this Report.

i. Deposits:

The Company has not accepted or renewed any amount falling within the purview of provisions of
Section 73 of the Companies Act 2013 (“the Act”) read with the Companies (Acceptance of Deposit)
Rules, 2014 during the year under review.

Hence, the requirement for furnishing details relating to deposits covered under Chapter V of the Act
or the details of deposits that are not in compliance with Chapter V of the Act is not applicable.

j. Loan from Directors or Director's Relative:

During the year under review company has not taken loans from Directors or Director's Relative.

k. Corporate Social responsibility f‘CSR'):

During the financial year 2024-2025, the provisions of Secon 135 of the Companies Act, 2013 were not
applicable to the Company i.e., the Company was not liable to / obligated to spent the amount towards CSR
for the period under review and hence disclosures related to the same are not applicable.

l. Particulars of Contracts or Arrangements with Related Parties:

All the related party transactions/contracts/arrangements that were entered into by the Company
during the year under review were on an arm's length basis and were in compliance with the applicable
provisions of the Act and the Listing Regulations.

There are no materially significant related party transactions entered into by the Company with its
Promoters, Directors, KMP's, or Senior Management Personnel that may have a potential conflict with
the interest of the Company at large.

All related party transactions as required under AS-18 are reported in the notes to the financial
statement of the Company.

All related party transactions were placed before the Audit Committee for its approval and noting on
a quarterly basis. Prior omnibus approval of the Audit Committee is obtained for the transactions
which are foreseen and of a repetitive nature.

The Company has also adopted a related party transaction policy.

The policy was approved by the Board and the same was uploaded on the company's website at
https://www.globalspace.in/uploads/Policies/RPT POLICY.pdf

m. Conservation of energy, technology absorption and foreign exchange earnings outgo:

The particulars as required under the provisions of Section 134(3) (m) of the Companies Act, 2013 read
along with Rule 8 of the Companies (Accounts) Rules, 2014 in respect of conservation of energy, technology
absorption, foreign exchange earnings and outgo etc. are as mentioned below:

A) Conservation of energy:

Steps taken or impact
on conservation of
energy.

The operations of the Company do not involve high energy consumption.
However, the Company has for many years now been laying great emphasis
on the Conservation of Energy and has taken several measures including
regular monitoring of consumption, implementation of viable energy saving
proposals, improved maintenance of systems etc.

Steps taken by the
company for utilizing
alternate sources of
energy.

None

Capital investment on
energy conservation
Equipment's

Nil

(B) Technology absorption:

Efforts made towards technology absorption

None

Benefits derived like product improvement, cost reduction, product
development or import substitution

In case of imported technology (imported during the last three years reckoned from the
beginning of the financial year):

• Details of technology imported

None

• Year of import

Not Applicable

• Whether the technology has been fully absorbed

Not Applicable

• If not fully absorbed, areas where absorption has not taken place, and
the reasons thereof

Not Applicable

Expenditure incurred on Research and Development

Nil

(C) Foreign exchange earnings and Outgo:

April 01, 2024, to
March 31, 2025
[2024-2025]

April 01, 2023, to March 31, 2024
[2023-2024]

Amount in INR

Amount in INR

Actual Foreign Exchange earnings

NIL

NIL

Actual Foreign Exchange outgo

NIL

NIL

n. Annual Return:

Pursuant to the provisions of Section 92(3) read with Section 134(3)(a) of Companies Act, 2013, the Annual
Return as on March 31, 2025, is available on Company's website at

https://www.globalspace.in/investors.php

o. Particulars of Loans granted, Guarantees given, or Investments made, or security provided under
Section 186 of the Companies Act, 2013:

Details of Loans granted, Guarantees given, and Investments made during the year under review, covered
under the provisions of Section 186 of the Act, are given in Note to the standalone financial statements in
the Annual Report.

p. Disclosure under Section 134(3)fi) of the Companies Act, 2013:

There are no material changes or commitments affecting the financial position of the Company, subsequent
to the close of the Financial Year 2024-2025 till the date of this Report.

q. Internal Financial Control Systems and their adequacy:

The Company has its internal financial control systems commensurate with the size and complexity of its
operations, to ensure proper recording of financials and monitoring of operational effectiveness and
compliance of various regulatory and statutory requirements. The management regularly monitors the
safeguarding of its assets, prevention and detection of frauds and errors, accuracy and completeness of the
accounting records including timely preparation of reliable financial information.

The internal auditor consults and reviews the effectiveness and efficiency of the internal financial control
systems and procedure to ensure that all the assets are protected against loss and that the financial and
operational information is accurate and complete in all respects. Significant audit observations and
corrective actions thereon are presented to the Audit Committee of the Company.

r. Details of Utilization of funds raised through Preferential Allotment or Qualified Institutions
Placement as Specified under Regulation 32(7A) :

During the year under review the Company has not raised any funds through preferential allotment or
Qualified Institution Placements or any other means.

2. MATTERS RELATED TO DIRECTORS AND KEY MANAGERIAL PERSONNEL:

a. Board of Directors & Key Managerial Personnel (KMP):

i. Appointment:

There are no appointments of Directors or KMPs during the Financial Year ended March 31, 2025.

However, after the end of Financial Year 2024-2025, Company has appointed Mr. Pulkit K Chowdhary (DIN:
11198535) appointed as an Additional Independent Director of the company w.e.f August 12, 2025.

ii. Details of the Directors and KMP's resigned during the year:

There were 1 resignation of Directors or KMPs during the Financial Year under review:

• Mr. Amit Verma, (DIN: 07046152) Executive Director of the Company , resigned w.e.f. April 02, 2024.

However, after the end of Financial Year 2024-25, Mrs. Asha Sampath, (DIN: 02160962) Independent
Director of the Company, resigned w.e.f. August 07, 2025.

Further, the composition of the Board of Directors is in due compliance of the Companies Act, 2013 (the
'Act') and SEBI Listing Regulations.

As of March 31, 2025, the Board of the Company comprises of 5 Directors out of which 1 is Managing
Director, 1 is Non-Executive Director Non-Independent Director, and 3 are Independent Directors which
are provided below:

Sr. No.

Name of Directors & KMP's

Designation

DIN/PAN

1.

Mr. Krishna Murari Singh

Chairman and Managing Director

03160366

2.

Mrs. Beauty Krishnamurari Singh

Non-Executive Director Non¬
Independent Director

03481024

4.

Mr. Girish Kasaragode Mallya

Independent Director

09533336

5.

Mrs. Asha Sampath*

Independent Director

02160962

6.

Ms. Lucky Bansal

Independent Director

09298816

7.

Ms. Ankita Omprakash Kyal

Company Secretary & Compliance
Officer

AVXPK1852A

8.

Mr. Rajesh Vishwanath Chorasia

Chief Financial Officer

ADBPC0955C

* Resigned w.e.f. August 07,2025

b. Retirement by Rotation

In accordance with the provisions of the Act, none of the Independent Directors are liable to retire by
rotation.

A proposal for re-appointment of Mr. Krishna Murari Singh, the Managing Director the retiring director of
the Company shall be placed before the shareholders of the Company at the ensuing Annual General
Meeting as per the provisions of Section 152(6) of the Companies Act, 2013 read with the Companies
(Appointment and Qualification of Directors) Rules, 2014.

Your directors recommend their approval.

c. Declaration by Independent Directors:

The Company has duly complied with the definition of 'Independence' according to the provisions of Section
149(6) of, read along with Schedule IV to the Companies Act, 2013 i.e., Code of Independent Directors and
Regulation 16 (1) (b) and Regulation 25 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations 2015 (as amended).

All the Independent Director/s have submitted a declaration that he/she meets the criteria of
independence and submits the declaration regarding the status of holding other directorship and
membership as provided under law.

The Independent Directors have also confirmed that they have complied with the Company's code of
conduct for Board and Senior Management as per Regulation 26(3) of SEBI (Listing Obligations &
Disclosure Requirements) Regulations, 2015.

The Independent Directors affirmed that none of them were aware of any circumstance or situation which
could impair their ability to discharge their duties in an independent manner.

d. Evaluation by Independent Director

In a separate meeting of Independent Directors held on February 11, 2025, performance of non¬
independent directors, performance of the Board as a whole and performance of the Chairman was
evaluated, considering the views of executive director.

e. Disqualification of Directors:

During the financial year 2024-2025 under review, the Company has received Form DIR-8 from all
Directors as required under the provisions of Section 164(2) of the Companies Act, 2013 read with
Companies (Appointment and Qualification of Directors) Rules, 2014.

Further the Company has also taken a certificate of non-disqualificaon of directors pursuant to Regulation
34(3) and Schedule V Para C clause (10)(i) of the SEBI (Listing Obligation and Disclosure Requirements)
Regulation, 2015) which is enclosed with the annual report.

3. DISCLOSURE RELATED TO BOARD, COMMITTEES AND POLICIES

a) Board Meetings:

During the year under review the Board of Directors met 7 times at their meeting held on May 04, 2 024;
May 28, 2024; May 30, 2024; August 12, 2024; November 14, 2024; December 09, 2024; February 11,
2025;

Gap between two Board meetings during the year under review did not exceed one hundred and twenty
days. A requisite quorum was present for all the meetings.

The attendance of the Board members at the Board meetings held during the year is as follows:

Name of the Directors

Designation

No. of Meetings
held

No. of Meetings
Attended

Mr. Krishna Murari Singh

Managing Director

7

7

Mrs. Beauty Krishnamurari
Singh

Non-Executive Director

7

3

Mrs. Asha Sampath*

Non-Executive Independent
Director

7

7

Ms. Lucky Bansal

Non-Executive Independent
Director

7

7

Mr. Girish Kasaragode
Mallya

Non-Executive Independent
Director

7

7

* Mrs. Asha Sampath resigned w.e.f August 07,2025
b) Audit Committee:

The Audit Committee of Board of Directors is constituted pursuant to the provisions of Section 177 of the
Companies Act, 2013 and Regulation 18 of Securities Exchange and Board of India (Listing Obligation and
Disclosure Requirements) Regulations, 2015. The composition of the Audit Committee is in conformity
with the provisions of the said section and Regulation and there was no change in the composition of the
audit committee during the financial year under review.

The Audit Committee Comprises of:

Name of Members

Designation

Mr. Girish Kasaragode Mallya

Non-Executive Independent Director (Chairperson)

Mr. Krishna Murari Singh

Managing Director (Member)

Mrs. Asha Sampath*

Non-Executive Independent Director (Member)

* Mrs. Asha Sampath resigned w.e.f August 07,2025

All members of the Audit Committee have the requisite qualification for appointment on the Committee
and possess sound knowledge of finance, accounting practices and internal controls.

The Company Secretary of the Company acts as a secretary to the Committee.

The Audit Committee met 7 times during the financial year ended on May 04, 2024; May 28, 2024; May
30, 2024; August 12, 2024; November 14, 2024; December 09, 2024; February 11, 2025.

The attendance of the members at the Audit committee meetings held during the year is as follows:

Name of Members

Designation

No. of Meetings held

No. of Meetings Attended

Mr. Girish Kasaragode Mallya

Chairman

7

7

Mr. Krishna Murari Singh

Member

7

7

Mrs. Asha Sampath*

Member

7

7

Mrs. Lucky Bansal

Member

7

7

* Mrs. Asha Sampath resigned w.e.f August 07,2025

During the financial year under review, the Board of Directors of the Company accepted all the
recommendations of the Audit Committee.

c) Nomination & Remuneration Committee:

The Nomination and Remuneration Committee of the Board of Directors is constituted pursuant to the
provisions of Section 178 of the Companies Act, 2013 and Regulation 19 of Securities Exchange and Board
of India (Listing Obligation and Disclosure Requirements) Regulations, 2015. The composition of the
Nomination & Remuneration Committee is in conformity with the provisions of the said section and
Regulation and there was no change in the composition of the nomination & remuneration committee
during the financial year under review.

The Nomination & Remuneration Committee comprises of:

Name of Members

Designation

Mr. Girish Kasaragode Mallya

Chairman (Independent Director)

Mrs. Beauty Krishna Murari Singh

Member (Independent Director)

Mrs. Asha Sampath*

Member (Non-Executive Director)

* Mrs. Asha Sampath resigned w.e.f August 07,2025

The Board has in accordance with the provisions of sub-section (3) of Section 178 of the Companies Act,
2013, formulated the policy setting out the criteria for determining qualifications, positive attributes,
independence of a Director, and policy relating to selection and remuneration for Directors, Key
Managerial Personnel and Senior Management Employees.

Major criteria/gist defined in the policy framed for appointment of and payment of remuneration to the
Directors of the Company, are as under:

Minimum Qualification
Positive Attributes
Independence
Experience

The Nomination and Remuneration Policy of the Company pursuant to provisions of Section 178 (3) and
(4) of the Companies Act, 2013 is published on the website of the Company at
https://www.globalspace.in/uploads/Policies/NRC POLICY.pdf

The Nomination & Remuneration Committee met 1 time during the financial year ended on March 31,
2025, at their meeting held on August 12, 2024.

The attendance of the members at the Nomination & Remuneration committee meetings held during the
year is as follows:

Name of Members

Designation

No. of Meetings held

No. of Meetings Attended

Mr. Girish Kasaragode Mallya

Chairman

1

1

Mrs. Beauty Krishna Murari Singh

Member

1

1

Mrs. Asha Sampath*

Member

1

1

* Mrs. Asha Sampath resigned w.e.f August 07,2025

The Stakeholder & Relationship Committee of Directors was constituted pursuant to the provisions of
Section 178(5) of the Companies Act, 2013 and Regulation 20 of Securities Exchange and Board of India
(Listing Obligation and Disclosure Requirements) Regulations, 2015. The composition of the Stakeholder
Relationship Committee is in conformity with the provisions of the said section and Regulation and there
was no change in the composition of the Stakeholder Relationship Committee during the financial year
under review.

The Stakeholder & Relationship Committee comprises of:

Name of Members

Designation

Mrs. Beauty Krishna Murari Singh

Chairman (Non-Executive Non-Independent Director)

Mr. Krishna Murari Singh

Member (Managing Director)

Mr. Girish Kasaragode Mallya

Member (Non-Executive Independent Director)

The Company Secretary of the Company acts as the Secretary of the Stakeholders' Relationship
Committee.

The Stakeholders' Relationship Committee met 1 times during the financial year ended on March 31,
2025, at their meeting held on November 14, 2024.

The attendance of the members at the Stakeholders' Relationship Committee meetings held during the
year is as follows:

Name of Members

Designation

No. of Meetings held

No. of Meetings Attended

Mrs. Beauty Krishna Murari
Singh

Chairman

1

1

Mr. Krishna Murari Singh

Member

1

1

Mr. Girish Kasaragode Mallya

Member

1

1

e) Meeting of Independent Directors

In compliance with Schedule IV to the Companies Act, 2013 and Regulation 25 of the SEBI (Listing
Obligation and Disclosure Requirements) Regulations, 2015, the Independent Directors held their
separate meeting on February 11, 2025, without the attendance of non-independent directors and
members of management, inter alia, to discuss the following:

• Review the performance of non-independent directors and the Board as a whole.

• Review the performance of the Chairperson of the Company, considering the views of executive
directors and non-executive directors; and assess the quality, quantity, and timeliness of flow of
information between the Company Management and the Board that is necessary for the Board to
perform their duties effectively and reasonably.

All independent directors were present at the meeting, deliberated on the above and expressed their
satisfaction.

f) Vigil Mechanism for the Directors and Employees:

The Board of Directors of the Company have, pursuant to the provisions of Section 177(9) of the
Companies Act, 2013 read with Rule 7 of the Companies (Meetings of Board and its Powers) Rules, 2014,
framed “Vigil Mechanism Policy” for Directors and employees of the Company to provide a mechanism
which ensures adequate safeguards to employees and Directors from any victimization on the raising of
concerns of any violations of legal or regulatory requirements, incorrect or misrepresentation of any,
financial statements and reports, etc.

The employees of the Company have the right/option to report their concerns/grievances to the
Chairman of the Board of Directors and it also It provides direct access to the employees of the Company
to approach the Compliance Officer or the Chairman of the Audit Committee, where necessary. The

Company ensures that genuine whistle-blowers are accorded complete protection from any kind of unfair
treatment or victimization.

The Company is committed to adhering to the highest standards of ethical, moral, and legal conduct of
business operations.

The said policy is also available on the website of the Company
https://www.globalspace.in/uploads/Policies/WHISTLE BLOWER POLICY.pdf

g) Annual Evaluation of Directors. Committee and Board as a whole:

Pursuant to the provisions of the Section 134(3)(p) of the Companies Act, 2013 read with Rule 8(5)(iiia)
of Companies (the Board has carried out the formal annual performance evaluation of its own
performance, the Directors individually as well as the evaluation of the working of its various Committees
and the working of the Board as whole. The evaluation exercise was carried out on various aspects of the
Boards functioning such as composition of the Board & committees, experience & competencies,
performance of the duties and obligations, governance issues, etc.

The manner in which the evaluation has been carried out has been explained below:

• Performance Evaluation criteria: Separate exercise was carried out to evaluate the performance of
individual Directors including the Chairman by the Nomination and Remuneration committee as per
the structured mechanism who were evaluated on following parameters / criteria:

• Participation and contribution by a director,

• Commitment (including guidance provided to senior management outside of Board / Committee
meetings),

• Effective deployment of knowledge and expertise,

• Effective management of relationship with stakeholders,

• Integrity and maintenance of confidentiality,

• Independence of behavior and judgment,

• Observance of Code of Conduct, and

• Impact and influence

In the opinion of the Board, Independent Directors of the Company possess necessary expertise, integrity,
experience, and proficiency in their respective fields. Further, all Independent Directors have confirmed that
they have registered with the data bank of Independent Directors maintained by; and are either exempt or
have completed the online proficiency self -assessment test conducted by; the Indian Institute of Corporate
Affairs the in accordance with the provisions of Section 150 of the Act.

4. AUDITORS OF THE COMPANY:

a) Statutory Auditors:

Pursuant to the provisions of Secon 139 of the Companies Act, 2013 and the Companies (Audit and
Auditors) Rules, 2014, M/s. Bansi Lal Shah & Co., Chartered Accountants (Firm Reg. No.000384W), was
appointed as the Statutory auditors of the Company for the period commencing from the conclusion of the
AGM held on September 29, 2023, till the conclusion of AGM to be held in the F.Y. 2025-2 6.Accordingly, it
remains the Statutory auditor of the company during the year under review.

The Company proposes re-appointment of M/s. Bansi Lal Shah & Co, Chartered Accountants in the ensuing
Annual General Meeting for a second term of two years commencing from the conclusion of this Annual
General Meeting till the conclusion of the 17th Annual General Meeting of the Company to be held in the
financial year 2029-30.

The Company has received written consent and certificate of eligibility in accordance with Sections 139,
141 and other applicable provisions of the Companies Act, 2013 and Rules issued thereunder (including
any statutory modification(s) or re-enactment(s) for the me being in force), from M/s. Bansi Lal Shah & Co.,
Chartered Accountants. Further, they have confirmed that they hold a valid certificate issued by the Peer
Review Board of the Institute of Chartered Accountants of India (ICAI) as required under the Listing

b) Observations of Statutory auditors on accounts for the year ended March 31, 2025:

The observations / qualifications / disclaimers made by the Statutory Auditors in their report for the
financial year ended 31st March 2025 read with the explanatory notes therein are self-explanatory and
therefore, do not call for any further explanation or comments from the Board under Section 134(3) of the
Companies Act, 2013.

c) Reporting of frauds by statutory auditors under Section 143(12):

There were no incidents of reporting of frauds by Statutory Auditors of the Company under Section 143(12)
of the Act read with Companies (Accounts) Rules, 2014.

d) Secretarial Auditor:

Provisions of Section 204 read with Section 134(3) of the Companies Act, 2013, mandates to obtain
Secretarial Audit Report from a Practicing Company Secretary.

Accordingly, M/s. AJP & Associates, Practicing Company Secretaries had been appointed to issue Secretarial
Audit Report by the board on May 28, 2024, to issue Secretarial Audit Report for the financial year 2024¬
2025.

Secretarial Audit Report issued by M/s. AJP & Associates in Form MR-3 for the financial year 2024-2025
forms part of this report as
Annexure-II.

Observations of Secretarial auditors for the year ended March 31, 2025:

The replies to the comments of Secretarial Auditors in Auditors Report are as follows:

Sr.

No.

Observation Remark

Management Response

1.

The Company has failed to appoint a
common Independent Director on the
Board of the listed entity and its material
subsidiary M/s. Innopharm Healthcare
Private Limited for the period from May
04, 2024 to March 03, 2025 as per Reg.
24(1) of SEBI LODR.

M/s. Innopharm Healthcare Private Limited became
a material subsidiary w.e.f. May 4, 2024, under
Regulation 16(1)(c) of SEBI LODR. As required under
Regulation 24(1), a common Independent Director
was to be appointed on its Board.

However, due to inadvertent oversight, the Company
appointed the Independent Director of the Company
as a Non-Executive Director of the material
subsidiary on March 10, 2025, for complying with
this requirement.

The Company has since appointed the required
Independent Director and has strengthened internal
compliance mechanisms to prevent such delays in
the future.

2.

The Company has not submitted the Cash
flow statements for consolidated financial
results within the period prescribed for
the quarter ended September 30, 2024 as
per Reg. 33 of SEBI LODR.

The Consolidated Cash Flow Statement for the
quarter ended September 30, 2024, was submitted
on December 21, 2024. However, financials of the
subsidiary were not prepared for the said quarter
timely. Therefore, consolidated financial result was
submitted in delay.

Further, in compliance to Regulation 24A of Listing Regulations, M/s Innopharm Healthcare Private
Limited; the material unlisted subsidiaries of the Company have undertaken the secretarial audit for the
financial year 2024-2025.

The Secretarial audit reports of the material unlisted subsidiary is appended with the annual report of the
Company

e) Cost Auditors:

Pursuant to the provisions of Section 148 of the Companies Act, 2013 read with Notifications/Circulars
issued by the Ministry of Corporate Affairs from time to time, the Company is not required to appoint Cost
Auditor.

f) Maintenance of Cost records:

Pursuant to the provisions of Section 148 of the Companies Act, 2013 read with the Companies (Cost
Records and Audit) Rules, 2014, as amended from time to time, the Company is not required to maintain
Cost Records under said Rules.

g) Internal auditor:

In accordance with the provisions of Section 138 of the Companies Act, 2013 and Rules framed thereunder,
the Board has appointed M/s. Maheshwari and Maheshwari, Chartered Accountants as Internal Auditors to
conduct the Internal Audit of the Company for the Financial Year 2024-2025.

5. OTHER DISCLOSURES

Other disclosures as per provisions of Section 134 of the Act read with Companies (Accounts) Rules, 2014 are
furnished as under:

a. Details of significant and material orders passed by the Regulator or Court or Tribunal:

There were no significant and material orders issued against the Company by a regulating authority or
court or tribunal that could affect the going concern status and company's operation in future.

b. Risk Management Policy:

The Company has a risk management framework in place for identification and management of risks
including to identify, assess, monitor, and mitigate various nones to key business objectives. Major risks
identified by the businesses and functions are systematically addressed through mitigating actions on a
continuing basis. These are discussed at the meetings of the Audit Committee and the Board of Directors of
the Company.

c. Director's Responsibility Statement:

In terms of Section 134(5) of the Companies Act, 2013, in relation to the audited financial statements of the
Company for the year ended March 31, 2025, the Board of Directors hereby confirms that:

a. In the preparation of the annual accounts, the applicable accounting standards had been followed along
with proper explanation relating to material departures,

b. such accounting policies have been selected and applied consistently and the Directors made judgments
and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of
the Company as March 31, 2025, and of the profit/loss of the Company for that year,

c. proper and sufficient care was taken for the maintenance of adequate accounting records in accordance
with the provisions of this Act for safeguarding the assets of the Company and for preventing and
detecting fraud and other irregularities,

d. the annual accounts of the Company have been prepared on a going concern basis,

e. They have laid down Internal financial controls for ensuring the orderly and efficient conduct of its
business, including adherence to Company's policies, the safeguarding of its assets, the prevention and
detection of frauds and errors, the accuracy and completeness of the accounting records, and the timely
preparation of reliable financial information and,

f. proper systems have been devised to ensure compliance with the provisions of all applicable laws and
that such systems were adequate and operating effectively,

d. Disclosure regarding Internal Complaints Committee under the sexual harassment of women at
workplace (Prevention. Prohibition and Redressal) Act, 2013:

In accordance with the Sexual Harassment of Women at Workplace (Prevention, Prohibition, and
Redressal) Act, 2013 the Company has complied with the provisions relating to the constitution of the
Internal Complaints Committee and also framed and adopted the policy for the Prevention of Sexual
Harassment at Workplace.

The following is the summary of Sexual Harassment complaints received and disposed of during the year
2024-2025.

Particulars

Number

Number of cases pending as on the beginning of the financial year

NIL

Number of complaints filed during the year

NIL

Number of cases pending as on the end of the financial year

NIL

Number of cases pending for a period exceeding 90 days

NIL

The Company has submitted its Annual Report on the cases of Sexual Harassment of Women at Workplace
to the District Officer, Mumbai pursuant to section 21 of the aforesaid Act and Rules framed thereunder.

e. Statement on Compliance with Maternity Benefit Act. 1961:

During the year under review the Company has complied with the applicable provisions of
Maternity Benefit Act, 1961.

f. Disclosure under Section 43(a)(ii) of the Companies Act. 2013:

The Company has not issued any shares with differential rights and hence no information as per provisions
of Section 43 (a)(ii) of the Act read with Rule 4(4) of the Companies (Share Capital and Debenture) Rules,
2014 is furnished.

g. Disclosure under Section 54(1)(d) of the Companies Act. 2013:

The Company has not issued any sweat equity shares during the year under review and hence no
information as per provisions of Section 54(1)(d) of the Act read with Rule 8(13) of the Companies (Share
Capital and Debenture) Rules, 2014 is furnished.

h. Disclosure under Section 62(1)(b) of the Companies Act. 2013:

The Company has not issued any equity shares under Employees Stock Option Scheme during the year
under review and hence no information as per provisions of Section 62(1)(b) of the Act read with Rule
12(9) of the Companies (Share Capital and Debenture) Rules, 2014 is furnished.

i. Disclosure under Section 67(3) of the Companies Act. 2013:

During the year under review, there were no instances of non-exercising of voting rights in respect of shares
purchased directly by employees under a scheme pursuant to Section 67 (3) of the Act read with Rule 16(4)
of Companies (Share Capital and Debentures) Rules, 2014 is furnished.

j. Disclosure of proceedings pending. or application made under Insolvency and Bankruptcy Code.
2016:

No application was filed for corporate insolvency resolution process, by a financial or operational creditor
or by the company itself under the IBC before the NCLT.

k. Disclosure of reason for difference between valuation done at the time of taking loan from Bank and
at the time of One Time Settlement:

There was no instance of a one-time settlement with any Bank or Financial Institution.

l. Compliances of Secretarial Standards:

The Company is in compliance with all the applicable secretarial standards issued by the Institute of
Company Secretaries of India.

m. Particulars of Employees:

The particulars of remuneration to directors and employees and other related information required to be
disclosed under Section 197 (12) and sub rule 1 of rule 5 of the Companies (Appointment and
Remuneration of Managerial Personnel) Rules, 2014the Companies Act, 2013 and the Rules made
thereunder are given in
Annexure III to this Report.

As per the provisions of Section 197(12) of the Act read with Rule 5(2) and 5(3) of the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014, a statement containing names of
top ten employees in terms of remuneration drawn and the particulars of employees are provided in the
prescribed format and appended as
Annexure III to this report.

Further the Company has no employee who is in receipt of remuneration of either:

1. INR. 8,50,000/ per month or INR 1,02,00,000/ per annum or

2. Who receives in aggregate in excess of that drawn by the Managing Director or Whole Time Director of
the Company and holds by himself/herself along with his spouse and dependent children not less than
2% of the equity shares of the Company

n. Management Discussion and Analysis:

Management Discussion and Analysis Report as required under Regulation 34 and Schedule V of SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015 is furnished as
Annexure IV.

o. SEBI Complaints Redress System (SCORES):

The investor complaints are processed in a centralized web-based complaints redress system. The salient
features of this system are a centralized database of all complaints, online upload of Action Taken Reports
(ATRs) by the concerned companies, and online viewing by investors of actions taken on the complaint and
its current status. Your Company has been registered on SCORES and makes every effort to resolve all
investor complaints received through SCORES or otherwise within the statutory time limit from the receipt
of the complaint.

The Company has not received any complaint on the SCORES during the financial year 2024-2025.

p. Criteria for making payments to Non-Executive Directors:

Pursuant to Regulation 46(2)(f) the Board has framed the policy containing the criteria for making the
payments to non-executive directors.

The policy is available on the website at

https://www.globalspace.in/document/upload 20 feb/Criteira%20for%20Making%20payment%2 0to%
20NED/Criteria%20for%20payment%20to%20NED.pdf

q. Corporate Governance:

Your Company is committed to maintaining the highest standards of corporate governance. We believe
sound corporate governance is critical to enhance and retain investor trust. Our disclosures seek to attain
the best practices in corporate governance. The Board considers itself as trustee of its shareholders and
acknowledges its responsibilities towards them for the creation and safeguarding of their wealth. In order
to conduct business with these principles the company has created a corporate structure based on business
needs and maintains a high degree of transparency through regular disclosures with a focus on adequate
control systems.

As per provisions of Regulation 15 of SEBI (Listing Obligation and Disclosure Requirements) Regulations,
2015, the Corporate Governance Report for the financial year 2024-2025 is presented as
"Annexure V to
this Report.

r. Code of Conduct:

The Board has laid down a specific code of Conduct for all Board Members and Senior Management of the
Company. All the Board Members and Senior Management Personnel have affirmed compliance with the
Code on an annual basis. A declaration by the Managing Director stating that the Code of Conduct of the
Board of Directors and Senior Management is in Compliance is attached as
Annexure VI to this report.

s. Insider Trading:

The Board has in consultation with the Stakeholder's Relationship Committee laid down the policy to
regulate and monitor Insider Trading in the Company. The Committee regularly analyses the transactions
and monitors them to prevent Insider Trading.

The Company has also adopted a Prohibition of Insider Trading Policy.

t. Means of Communication:

The Board believes that effective communication of information is an essential component of Corporate
Governance. The Company regularly interacts with its shareholders through multiple channels of
communication such as the Company's Website and stipulated communications to the Stock Exchange
where the Company's shares are listed for the announcement of Financial Results, Annual Report, Notices,
Outcome of Meetings, and Company's Policies etc.

u. Human Resources:

Your Company treats its “Human Resources” as one of its most important assets. Your Company
continuously invests in the attraction, retention, and development of talent on an ongoing basis. A number
of programs that provide focused people's attention are currently underway. Your Company's thrust is on
the promotion of talent internally through job rotation and job enlargement.

As on March 31, 2025, there were a total of 25 employees. The Company has all the required policies under
the Indian laws for the time being in force and as required under the Companies Act, 2013 and SEBI LODR
Regulations, 2015 to protect and safeguard the interest of the employees.

v. Website:

The Company has a website addressed as https://www.globalspace.in/investors.php .Website contains the
basic information about the Company - details of its Business, Financial Information, Shareholding Pattern,
Contact Information of the Designated Official of the Company who is responsible for assisting and handling
investors grievances and such other details as may be required under sub regulation (2) of Regulation 46
of the Listing Regulations, 2015. The Company ensures that the contents of this website are periodically
updated.

w. Disclosure pursuant to Section 67(3) of Companies Act, 2013:

Disclosure in respect of voting rights not exercised directly by the employees in respect of shares to which
the scheme relates is not applicable to the Company during the financial year 2023-2024 pursuant to
Section 67(3) of the Companies Act, 2013 and rule 16(4) of Companies (Share Capital and Debenture)
Rules, 2014.

x. Disclosure pursuant to Schedule V Part II Section II of Companies Act, 2013:

The disclosure pursuant to Schedule V Part II Section II of Companies Act,2013 forms part of the Corporate
Governance report.

y. Indian Accounting Standards- IFRS Converge Standards:

The Ministry of Corporate Affairs vide its notification dated 16th February 2015 notified under Section 133
of the Companies Act 2013 read with Companies (Indian Accounting Standards) Rules, 2015. In pursuance
of the said notification your Company has prepared the financial statements to comply in all material
respects in accordance with the applicability of Indian Accounting Standards.

z. Listing on Stock Exchange:

The Equity shares of the Company listed on the Main Board of Bombay Stock Exchange Limited (BSE).
aa. Depository System:

Your Company's equity shares are in Demat form. The Company has appointed Central Depository Services
India Limited (CDSL) as designated depository to the Company.

bb. Awards and Achievements:

Your Company has received no awards during F.Y 2024-2025.
cc. Annual Listing Fees to the Stock Exchanges:

Globalspace Technologies Limited have listed its equity shares on the Main Board of Bombay Stock
Exchange Limited. The listing fees have been duly paid to the exchange and annual custodial fees have been
paid to CDSL and NSDL for F.Y. 2024-2025.

6. ACKNOWLEDGEMENTS AND APPRECIATION:

Your directors take this opportunity to thank the customers, shareholders, suppliers, bankers, business
partners/associates, financial institutions and Central and State Governments for their consistent support and
encouragement to the Company.

For and on behalf of the Board

For and on behalf of Globalspace Technologies Limited
SD/- SD/-

Krishna Murari Singh Beauty Krishna Murari Singh

Managing Director Non-Executive Director

DIN: 03160366 DIN: 03481024

Date: August 12, 2025 Date: August 12, 2025

Place: Mumbai Place: Mumbai

 
STOCKS A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z|Others

Mutual Fund A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others

Registered Office : 402, Nirmal Towers, Dwarakapuri Colony, Punjagutta, Hyderabad - 500082.
SEBI Registration No's: NSE / BSE / MCX : INZ000166638. Depository Participant: IN- DP-224-2016.
AMFI Registered Number - 29900 (ARN valid upto 24th July 2028) - AMFI-Registered Mutual Fund Distributor since June 2008.
Compliance Officer :- Name: Ch.V.A. Varaprasad, Mobile No.: 9393136201, E-mail:
Grievance Cell: rlpsec_grievancecell@yahoo.com , rlpdp_grievancecell@yahoo.com
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
Copyrights @ 2014 © RLP Securities. All Right Reserved Designed, developed and content provided by